Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
19.03.26
/
50%
€88.00
Target price
19.03.27
€108.80
Performance (%)
-1.70%
Price
20.03.26
€86.50
Summary
This prediction is currently active. With a performance of -1.70%, the BUY prediction for Protagonist Therapeutics Inc by Citigroup_Inc_ is down slightly. This prediction currently runs until 19.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Protagonist Therapeutics Inc | -1.70% |
| iShares Core DAX® | -2.117% |
| iShares Nasdaq 100 | -1.323% |
| iShares Nikkei 225® | -0.324% |
| iShares S&P 500 | -1.568% |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Citigroup Inc. from $115.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€74.00
10.11.25
10.11.25
€84.79
10.11.26
10.11.26
16.89%
20.03.26
20.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
98.39%
20.03.26
20.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€46.40
17.06.25
17.06.25
€62.32
17.06.26
17.06.26
86.42%
20.03.26
20.03.26